Suppr超能文献

一名SARS-CoV-2两次复阳的新冠康复患者的宿主免疫反应:病例报告

The host immune response of a discharged COVID-19 patient with twice reemergence of SARS-CoV-2: a case report.

作者信息

Zao Xiaobin, Zhou Yang, Liang Yijun, Cao Xu, Chen Hening, Li Xiaoke, Ye Yong'an

机构信息

Dongzhimen Hospital, Beijing University of Chinese Medicine, 5 Haiyuncang Rd, Dongcheng District, Beijing, 100700, People's Republic of China.

Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, 5 Haiyuncang Rd, Dongcheng District, Beijing, 100700, People's Republic of China.

出版信息

BMC Infect Dis. 2021 Sep 23;21(1):991. doi: 10.1186/s12879-021-06679-3.

Abstract

BACKGROUND

The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. There have been reports that long-term SARS-CoV-2 RNA shedding and re-infection of COVID-19 patients existed. However, the specific mechanism, diagnosis, and treatment of COVID-19 are still unclarified.

CASE PRESENTATION

In this case, we reported a 64-year-old patient who had a long-term course of COVID-19 for 174 days with two retests of SARS-CoV-2 RNA positive after discharging from the hospital. The patient's serum immunoglobulin G (IgG) of SARS-CoV-2 tested positive after the initial infection. And during treatment, the CD4 + T cell count and ratio to peripheral blood mononuclear cell (PBMC) were in dynamic change.

CONCLUSIONS

Our results suggested that the host immune system responded with IgG production after SARS-CoV-2 infection, but was not protective enough for the patient. The reemergence of SARS-CoV-2 could be related to the cell count and proportion of CD4 + T cells in PBMC. And the increase of CD4 + T cells after treatment may help to clear the virus.

摘要

背景

由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的2019冠状病毒病(COVID-19)已成为全球大流行疾病。有报道称,COVID-19患者存在长期SARS-CoV-2 RNA脱落及再次感染的情况。然而,COVID-19的具体机制、诊断及治疗仍不明确。

病例介绍

在此病例中,我们报告了一名64岁患者,其COVID-19病程长达174天,出院后两次复查SARS-CoV-2 RNA均呈阳性。该患者初次感染后SARS-CoV-2血清免疫球蛋白G(IgG)检测呈阳性。且在治疗期间,外周血CD4+T细胞计数及占外周血单个核细胞(PBMC)的比例呈动态变化。

结论

我们的结果表明,SARS-CoV-2感染后宿主免疫系统产生了IgG应答,但对患者的保护作用不足。SARS-CoV-2的再次出现可能与PBMC中CD4+T细胞的计数及比例有关。治疗后CD4+T细胞增加可能有助于清除病毒。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验